ClinConnect ClinConnect Logo
Search / Trial NCT03368313

Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis

Launched by PRÓ CIRCULAÇÃO® · Dec 8, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Nonelastic Compression Theraphy Compression Theraphy Compression Stockings

ClinConnect Summary

This clinical trial is studying the use of special compression garments to help patients with deep vein thrombosis (DVT), a condition where blood clots form in the deep veins of the legs. The trial compares two groups: one group will wear a high-pressure non-elastic compression garment called Circaid, while the other group will not wear any compression garment. Researchers want to see if wearing the Circaid garment will help reduce pain and swelling in the legs more quickly and lower the chances of developing post-thrombotic syndrome—a common complication after DVT—within six months.

To be eligible for this trial, participants should be between 18 and 80 years old, diagnosed with acute DVT in the lower leg, and experiencing symptoms for less than two weeks. The study is looking for outpatients who have not had any previous history of DVT and who can walk. Participants can expect to wear the compression garment for the duration of the study and will be monitored for changes in their symptoms. This research is currently recruiting participants, and it aims to provide valuable insights into better ways to manage DVT and its complications.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-80 years
  • Outpatients with acute deep venous thrombosis of lower extremity
  • Symptomatic patients
  • Involving femoro-popliteal and / or ilofemoral segment
  • Symptoms less than two weeks
  • Provoked or unprovoked TVP
  • Exclusion Criteria:
  • History of TVP
  • Any allergy to the use of compression material
  • Severe arterial occlusive disease
  • Patients in whom thrombus removal is planned
  • Ankle index \<0.5
  • Inability to walk
  • A life expectancy of less than six months
  • Geographic inaccessibility that prevents adequate follow-up with or without assistance
  • Thrombolytic therapy outside of this study for the initial treatment of acute DVT.

About Pró Circulação®

Pró Circulação® is a leading clinical trial sponsor dedicated to advancing cardiovascular health through innovative research and development. With a focus on enhancing patient outcomes, the organization collaborates with healthcare professionals and institutions to design and execute rigorous clinical studies. Pró Circulação® is committed to fostering scientific excellence, adhering to regulatory standards, and ensuring the ethical conduct of trials. By leveraging cutting-edge methodologies and a patient-centered approach, the company aims to contribute to the global understanding of cardiovascular diseases and improve therapeutic options for patients.

Locations

Curitiba, Pr, Brazil

Curitiba, Parana, Brazil

Bahia, Ba, Brazil

Goiânia, Go, Brazil

Cuiabá, Mount, Brazil

Recife, Pe, Brazil

Cascavel, Pr, Brazil

Curitiba, Pr, Brazil

Curitiba, Pr, Brazil

Curitiba, Pr, Brazil

Londrina, Pr, Brazil

Natal, Rn, Brazil

Porto Alegre, Rs, Brazil

Porto Alegre, Rs, Brazil

Tubarão, Sc, Brazil

Xanxerê, Sc, Brazil

Santos, Sp, Brazil

São José Do Rio Preto, Sp, Brazil

São Paulo, Sp, Brazil

Patients applied

0 patients applied

Trial Officials

Eduardo Matta, MD

Principal Investigator

Pró Circulação®

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials